Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2021/11/037874
CTRI/2021/11/037874
Not yet recruiting
Phase 4

Flexible Percutaneous Transhepatic Cholangiopancreatoscopy (PTCS) in Complex Pancreaticobiliary Disease

Boston Scientific Corporation0 sites0 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHealth Condition 1: K00-K95- Diseases of the digestive system

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Health Condition 1: K00-K95- Diseases of the digestive system
Sponsor
Boston Scientific Corporation
Status
Not yet recruiting
Last Updated
3 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Observational

Investigators

Eligibility Criteria

Inclusion Criteria

  • •1\.Scheduled for a percutaneous transhepatic procedure to access the pancreaticobiliary anatomy that will accommodate passage of SpyGlassââ??¢ Discover Digital Catheter per local standard of practice
  • •2\.Written informed consent from patient or legally authorized representative of the patient

Exclusion Criteria

  • •1\. Contraindication for cholangiopancreatoscopy
  • •2\. Subjects with unresolved adverse event(s) associated with prior percutaneous pancreaticobiliary ductal access
  • •3\. \<18 years of age
  • •4\. Potentially vulnerable subjects, including, but not limited to pregnant women

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
SpyGlass™ Discover PercutaneousPancreatic DiseasesBile Duct ObstructionBile Duct Diseases
NCT04580940Boston Scientific Corporation50
Not yet recruiting
Not Applicable
Role of gall bladder cholangiography in evaluation of infants suspected with absence of bile ducts
CTRI/2020/03/023956Vivek Kumar Garg
Recruiting
Not Applicable
Percutaneous Transhepatic Biliary Drainage (PTBD) in Patients with non-dilated Biliary System: Technical and Clinical OutcomesC22.1Intrahepatic bile duct carcinoma
DRKS00027239Klinikum der Universität München, Campus Großhadern80
Active, not recruiting
Not Applicable
Covered Transjugular Intrahepatic Portosystemic Stent Shunt versus Optimized medical Treatment for the Secondary Prevention of Variceal Bleeding in Cirrhosisliver cirrhosisesophageal (variceal) bleeding
EUCTR2005-003557-27-DEDean of the Medical Faculty (University of Bonn)
Completed
Not Applicable
Covered transjugular intrahepatic portosystemic stent shunt versus optimised medical treatment for the secondary prevention of variceal bleeding in cirrhosis
ISRCTN16334693Individual sponsor (Germany)186